{"disease":{"id":"quizartinib","name":"quizartinib"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04459598","title":"A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Daiichi Sankyo Co., Ltd.","has_results":true},{"nct_id":"NCT04459585","title":"A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Daiichi Sankyo Co., Ltd.","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}